Skip to main content

Advertisement

SpringerLink
Log in

Harmful effects of functional hypercortisolism: a working hypothesis

  • Review
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Functional hypercortisolism (FH) is caused by conditions able to chronically activate hypothalamic–pituitary–adrenal axis and usually occurs in cases of major depression, anorexia nervosa, bulimia nervosa, alcoholism, diabetes mellitus, simple obesity, polycystic ovary syndrome, obstructive sleep apnea syndrome, panic disorder, generalized anxiety disorder, shift work, and end-stage renal disease. Most of these states belong to pseudo-Cushing disease, a condition which is difficult to distinguish from Cushing’s syndrome and characterized not only by biochemical findings but also by objective ones that can be attributed to hypercortisolism (e.g., striae rubrae, central obesity, skin atrophy, easy bruising, etc.). This hormonal imbalance, although reversible and generally mild, could mediate some systemic complications, mainly but not only of a metabolic/cardiovascular nature, which are present in these states and are largely the same as those present in Cushing’s syndrome. In this review we aim to discuss the evidence suggesting the emerging negative role for FH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. C. Tsigos, G.P. Chousos, Hypothalamic–pituitary–adrenal axis, neuroendocrine factors and stress. J. Psychosom. Res. 53, 865–871 (2002)

    PubMed  Google Scholar 

  2. G. Arnaldi, T. Mancini, G. Tirabassi, L. Trementino, M. Boscaro, Advances in the epidemiology, pathogenesis, and management of Cushing’s syndrome complications. J. Endocrinol. Invest. 35, 434–448 (2012)

    CAS  PubMed  Google Scholar 

  3. G. Arnaldi, A. Angeli, A.B. Atkinson, X. Bertagna, F. Cavagnini, G.P. Chrousos, G.A. Fava, J.W. Findling, R.C. Gaillard, A.B. Grossman, B. Kola, A. Lacroix, T. Mancini, F. Mantero, J. Newell-Price, L.K. Nieman, N. Sonino, M.L. Vance, A. Giustina, M. Boscaro, Diagnosis and complications of Cushing’s syndrome: a consensus statement. J. Clin. Endocrinol. Metab. 88, 5593–5602 (2003)

    CAS  PubMed  Google Scholar 

  4. G. Arnaldi, G. Tirabassi, R. Papa, G. Furlani, L. Trementino, M. Cardinaletti, E. Faloia, M. Boscaro, Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing’s disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis. Eur. J. Endocrinol. 160, 891–898 (2009)

    CAS  PubMed  Google Scholar 

  5. G. Tirabassi, E. Faloia, R. Papa, G. Furlani, M. Boscaro, G. Arnaldi, Use of the desmopressin test in the differential diagnosis of pseudo-Cushing state from Cushing’s disease. J. Clin. Endocrinol. Metab. 95, 1115–1122 (2010)

    CAS  PubMed  Google Scholar 

  6. G. Tirabassi, R. Papa, E. Faloia, M. Boscaro, G. Arnaldi, Corticotrophin-releasing hormone and desmopressin tests in the differential diagnosis between Cushing’s disease and pseudo-Cushing state: a comparative study. Clin. Endocrinol. (Oxf) 75, 666–672 (2011)

    CAS  Google Scholar 

  7. L.K. Nieman, B.M. Biller, J.W. Findling, J. Newell-Price, M.O. Savage, P.M. Stewart, V.M. Montori, The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 93, 1526–1540 (2008)

    CAS  PubMed Central  PubMed  Google Scholar 

  8. S.A. Doi, J. Clark, A.W. Russell, Concordance of the late night salivary cortisol in patients with Cushing’s syndrome and elevated urine-free cortisol. Endocrine 43, 327–333 (2013)

    CAS  PubMed  Google Scholar 

  9. H. Raff, Update on late-night salivary cortisol for the diagnosis of Cushing’s syndrome: methodological considerations. Endocrine 44, 346–349 (2013)

    CAS  PubMed  Google Scholar 

  10. H. Raff, Salivary cortisol and the diagnosis of Cushing’s syndrome: a coming of age. Endocrine 41, 353–354 (2012)

    CAS  PubMed  Google Scholar 

  11. Z.E. Belaya, A.V. Iljin, G.A. Melnichenko, L.Y. Rozhinskaya, N.V. Dragunova, L.K. Dzeranova, S.A. Butrova, E.A. Troshina, I.I. Dedov, Diagnostic performance of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay in obese and overweight patients referred to exclude Cushing’s syndrome. Endocrine 41, 494–500 (2012)

    CAS  PubMed  Google Scholar 

  12. C.A. Carrasco, M. García, M. Goycoolea, J. Cerda, J. Bertherat, O. Padilla, D. Meza, N. Wohllk, T. Quiroga, Reproducibility and performance of one or two samples of salivary cortisol in the diagnosis of Cushing’s syndrome using an automated immunoassay system. Endocrine 41, 487–493 (2012)

    CAS  PubMed  Google Scholar 

  13. M.D. Sullivan, P. O’Connor, P. Feeney, D. Hire, D.L. Simmons, D.W. Raisch, L.J. Fine, K.M. Narayan, M.K. Ali, W.J. Katon, Depression predicts all-cause mortality: epidemiological evaluation from the ACCORD HRQL substudy. Diabetes Care 35, 1708–1715 (2012)

    CAS  PubMed Central  PubMed  Google Scholar 

  14. M.S. Player, L.E. Peterson, Anxiety disorders, hypertension, and cardiovascular risk: a review. Int. J. Psychiatry Med. 41, 365–377 (2011)

    PubMed  Google Scholar 

  15. H. Teede, A. Deeks, L. Moran, Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 8, 41 (2010)

    CAS  PubMed Central  PubMed  Google Scholar 

  16. A. Pan, N. Keum, O.I. Okereke, Q. Sun, M. Kivimaki, R.R. Rubin, F.B. Hu, Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care 35, 1171–1180 (2012)

    PubMed Central  PubMed  Google Scholar 

  17. C. Gragnoli, Depression and type 2 diabetes: cortisol pathway implication and investigational needs. J. Cell. Physiol. 227, 2318–2322 (2012)

    CAS  PubMed  Google Scholar 

  18. D. Kopf, S. Westphal, C.W. Luley, S. Ritter, M. Gilles, B. Weber-Hamann, F. Lederbogen, H. Lehnert, F.A. Henn, I. Heuser, M. Deuschle, Lipid metabolism and insulin resistance in depressed patients: significance of weight, hypercortisolism, and antidepressant treatment. J. Clin. Psychopharmacol. 24, 527–531 (2004)

    CAS  PubMed  Google Scholar 

  19. Z. Rihmer, M. Arató, Depression and diabetes mellitus. A study of the relationship between serum cortisol and blood sugar levels in patients with endogenous depression. Neuropsychobiology 8, 315–318 (1982)

    CAS  PubMed  Google Scholar 

  20. B. Weber-Hamann, F. Hentschel, A. Kniest, M. Deuschle, M. Colla, F. Lederbogen, I. Heuser, Hypercortisolemic depression is associated with increased intra-abdominal fat. Psychosom. Med. 64, 274–277 (2002)

    PubMed  Google Scholar 

  21. G. Veen, E.J. Giltay, R.H. DeRijk, I.M. van Vliet, J. van Pelt, F.G. Zitman, Salivary cortisol, serum lipids, and adiposity in patients with depressive and anxiety disorders. Metabolism 58, 821–827 (2009)

    CAS  PubMed  Google Scholar 

  22. B. Pfohl, M. Rederer, W. Coryell, D. Stangl, Association between post-dexamethasone cortisol level and blood pressure in depressed inpatients. J. Nerv. Ment. Dis. 179, 44–47 (1991)

    CAS  PubMed  Google Scholar 

  23. N. Vogelzangs, K. Suthers, L. Ferrucci, E.M. Simonsick, A. Ble, M. Schrager, S. Bandinelli, F. Lauretani, S.V. Giannelli, B.W. Penninx, Hypercortisolemic depression is associated with the metabolic syndrome in late-life. Psychoneuroendocrinology 32, 151–159 (2007)

    CAS  PubMed Central  PubMed  Google Scholar 

  24. S. Komatsu, M. Yamamoto, K. Arishima, Y. Eguchi, Maternal adrenocortical hormones maintain the early development of pancreatic B cells in the fetal rat. J. Anat. 193, 551–557 (1998)

    CAS  PubMed Central  PubMed  Google Scholar 

  25. J.N. Mann, J.H. Thakore, Melancholic depression and abdominal fat distribution: a mini-review. Stress 3, 1–15 (1999)

    CAS  PubMed  Google Scholar 

  26. J.H. Thakore, P.J. Richards, R.H. Reznek, A. Martin, T.G. Dinan, Increased intra-abdominal fat deposition in patients with major depressive illness as measured by computed tomography. Biol. Psychiatry 41, 1140–1142 (1997)

    CAS  PubMed  Google Scholar 

  27. B.W. Penninx, A.T. Beekman, A. Honig, D.J. Deeg, R.A. Schoevers, J.T. van Eijk, W. van Tilburg, Depression and cardiac mortality: results from a community-based longitudinal study. Arch. Gen. Psychiatry. 58, 221–227 (2001)

    CAS  PubMed  Google Scholar 

  28. M. Vythilingam, J. Chen, J.D. Bremner, C.M. Mazure, P.K. Maciejewski, J.C. Nelson, Psychotic depression and mortality. Am. J. Psychiatry 160, 574–576 (2003)

    PubMed  Google Scholar 

  29. W. Coryell, J. Fiedorowicz, M. Zimmerman, E. Young, HPA-axis hyperactivity and mortality in psychotic depressive disorder: preliminary findings. Psychoneuroendocrinology 33, 654–658 (2008)

    CAS  PubMed Central  PubMed  Google Scholar 

  30. M.H. Kamphuis, Depression and cardiovascular disease: the role of diet, lifestyle and health (Gildeprint BV, Enschede (the Netherlands), 2006)

    Google Scholar 

  31. A.J. Broadley, A. Korszun, E. Abdelaal, V. Moskvina, J. Deanfield, C.J. Jones, M.P. Frenneaux, Metyrapone improves endothelial dysfunction in patients with treated depression. J. Am. Coll. Cardiol. 48, 170–175 (2006)

    CAS  PubMed  Google Scholar 

  32. L.J. Siever, T.W. Uhde, New studies and perspectives on the noradrenergic receptor system in depression: effects of the alpha 2-adrenergic agonist clonidine. Biol. Psychiatry 19, 131–156 (1984)

    CAS  PubMed  Google Scholar 

  33. A.J. Mitchell, T.R. Dening, Depression-related cognitive impairment: possibilities for its pharmacological treatment. J. Affect. Disord. 36, 79–87 (1996)

    CAS  PubMed  Google Scholar 

  34. A.L. Byers, K. Yaffe, Depression and risk of developing dementia. Nat. Rev. Neurol. 7, 323–331 (2011)

    CAS  PubMed Central  PubMed  Google Scholar 

  35. F. Thomson, M. Craighead, Innovative approaches for the treatment of depression: targeting the HPA axis. Neurochem. Res. 33, 691–707 (2008)

    CAS  PubMed  Google Scholar 

  36. M.W. Strachan, R.M. Reynolds, B.M. Frier, R.J. Mitchell, J.F. Price, The role of metabolic derangements and glucocorticoid excess in the aetiology of cognitive impairment in type 2 diabetes. Implications for future therapeutic strategies. Diabetes Obes. Metab. 11, 407–414 (2009)

    CAS  PubMed  Google Scholar 

  37. A.M. MacLullich, J.R. Seckl, Diabetes and cognitive decline: are steroids the missing link? Cell Metab. 7, 286–287 (2008)

    CAS  PubMed  Google Scholar 

  38. P.E. Stokes, The potential role of excessive cortisol induced by HPA hyperfunction in the pathogenesis of depression. Eur. Neuropsychopharmacol. 5(Suppl 1), 77–82 (1995)

    CAS  PubMed  Google Scholar 

  39. D.R. Rubinow, R.M. Post, R. Savard, P.W. Gold, Cortisol hypersecretion and cognitive impairment in depression. Arch. Gen. Psychiatry 41, 279–283 (1984)

    CAS  PubMed  Google Scholar 

  40. J.K. Belanoff, M. Kalehzan, B. Sund, S.K. Fleming Ficek, A.F. Schatzberg, Cortisol activity and cognitive changes in psychotic major depression. Am. J. Psychiatry 158, 1612–1616 (2001)

    CAS  PubMed  Google Scholar 

  41. B. Siegel, D. Gurevich, G.F. Oxenkrug, Cognitive impairment and cortisol resistance to dexamethasone suppression in elderly depression. Biol. Psychiatry 25, 229–234 (1989)

    CAS  PubMed  Google Scholar 

  42. J. Wauthy, M. Ansseau, R. von Frenckell, C. Mormont, J.J. Legros, Memory disturbances and dexamethasone suppression test in major depression. Biol. Psychiatry 30, 736–738 (1991)

    CAS  PubMed  Google Scholar 

  43. G. Winokur, D.W. Black, A. Nasrallah, DST nonsuppressor status: relationship to specific aspects of the depressive syndrome. Biol. Psychiatry 22, 360–368 (1987)

    CAS  PubMed  Google Scholar 

  44. A. Georgotas, R.E. McCue, O.M. Kim, W.E. Hapworth, B. Reisberg, P.M. Stoll, E. Sinaiko, C. Fanelli, P.E. Stokes, Dexamethasone suppression in dementia, depression, and normal aging. Am. J. Psychiatry 143, 452–456 (1986)

    CAS  PubMed  Google Scholar 

  45. D.A. Axelson, P.M. Doraiswamy, W.M. McDonald, O.B. Boyko, L.A. Tupler, L.J. Patterson, C.B. Nemeroff, E.H. Ellinwood Jr, K.R. Krishnan, Hypercortisolemia and hippocampal changes in depression. Psychiatry Res. 47, 163–173 (1993)

    CAS  PubMed  Google Scholar 

  46. G. Cizza, P. Ravn, G.P. Chrousos, P.W. Gold, Depression: a major, unrecognized risk factor for osteoporosis? Trends Endocrinol. Metab. 12, 198–203 (2001)

    CAS  PubMed  Google Scholar 

  47. G. Cizza, S. Primma, G. Csako, Depression as a risk factor for osteoporosis. Trends Endocrinol. Metab. 20, 367–373 (2009)

    CAS  PubMed Central  PubMed  Google Scholar 

  48. K.M. Yazici, A. Akinci, A. Sütçü, L. Ozçakar, Bone mineral density in premenopausal women with major depressive disorder. Psychiatry Res. 117, 271–275 (2003)

    PubMed  Google Scholar 

  49. J.D. Amsterdam, M.B. Hooper, Bone density measurement in major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 22, 267–277 (1998)

    CAS  PubMed  Google Scholar 

  50. D. Michelson, C. Stratakis, L. Hill, J. Reynolds, E. Galliven, G. Chrousos, P. Gold, Bone mineral density in women with depression. N. Engl. J. Med. 335, 1176–1181 (1996)

    CAS  PubMed  Google Scholar 

  51. O. Altindag, A. Altindag, M. Asoglu, M. Gunes, N. Soran, Z. Deveci, Relation of cortisol levels and bone mineral density among premenopausal women with major depression. Int. J. Clin. Pract. 61, 416–420 (2007)

    CAS  PubMed  Google Scholar 

  52. U. Halbreich, N. Rojansky, S. Palter, M. Hreshchyshyn, J. Kreeger, Y. Bakhai, R. Rosan, Decreased bone mineral density in medicated psychiatric patients. Psychosom. Med. 57, 485–491 (1995)

    CAS  PubMed  Google Scholar 

  53. F. Eskandari, P.E. Martinez, S. Torvik, T.M. Phillips, E.M. Sternberg, S. Mistry, D. Ronsaville, R. Wesley, C. Toomey, N.G. Sebring, J.C. Reynolds, M.R. Blackman, K.A. Calis, P.W. Gold, G. Cizza, Premenopausal, Osteoporosis Women, Alendronate, Depression (POWER) Study Group, Low bone mass in premenopausal women with depression. Arch. Intern. Med. 167, 2329–2336 (2007)

    PubMed  Google Scholar 

  54. M.A. Tichomirowa, M.E. Keck, H.J. Schneider, M. Paez-Pereda, U. Renner, F. Holsboer, G.K. Stalla, Endocrine disturbances in depression. J. Endocrinol. Invest. 28, 89–99 (2005)

    CAS  PubMed  Google Scholar 

  55. W. Pitchot, J. Reggers, E. Pinto, M. Hansenne, M. Ansseau, Catecholamine and HPA axis dysfunction in depression: relationship with suicidal behavior. Neuropsychobiology 47, 152–157 (2003)

    CAS  PubMed  Google Scholar 

  56. E. Syvälahti, Dexamethasone suppression test and the levels of serum growth hormone, plasma vasopressin and plasma homovanillic acid in depressed in- and out-patients. Acta Psychiatr. Scand. 71, 105–110 (1985)

    PubMed  Google Scholar 

  57. F. Contreras, J.M. Menchon, M. Urretavizcaya, M.A. Navarro, J. Vallejo, G. Parker, Hormonal differences between psychotic and non-psychotic melancholic depression. J. Affect. Disord. 100, 65–73 (2007)

    CAS  PubMed  Google Scholar 

  58. K. O’Flynn, T.G. Dinan, Baclofen-induced growth hormone release in major depression: relationship to dexamethasone suppression test result. Am. J. Psychiatry 150, 1728–1730 (1993)

    PubMed  Google Scholar 

  59. R.J. Dolan, S.P. Calloway, The human growth hormone response to clonidine: relationship to clinical and neuroendocrine profile in depression. Am. J. Psychiatry 143, 772–774 (1986)

    CAS  PubMed  Google Scholar 

  60. F. Duval, M.C. Mokrani, J.P. Macher, Reply to letter to the editor. Psychoneuroendocrinology 32, 211–212 (2007)

    Google Scholar 

  61. S.D. Targum, A.C. Sullivan, S.M. Byrnes, Neuroendocrine interrelationships in major depressive disorder. Am. J. Psychiatry 139, 282–286 (1982)

    CAS  PubMed  Google Scholar 

  62. C. Kirkegaard, B.J. Carroll, Dissociation of TSH adrenocortical disturbances in endogenous depression. Psychiatry Res. 3, 253–264 (1980)

    CAS  PubMed  Google Scholar 

  63. M.P. Hage, S.T. Azar, The link between thyroid function and depression. J. Thyroid Res. (2012). doi:10.1155/2012/590648

    PubMed Central  PubMed  Google Scholar 

  64. M. Maes, M. Vandewoude, L. Maes, C. Schotte, P. Cosyns, A revised interpretation of the TRH test results in female depressed patients. Part I: TSH responses. Effects of severity of illness, thyroid hormones, monoamines, age, sex hormonal, corticosteroid and nutritional state. J. Affect. Disord. 16, 203–213 (1989)

    CAS  PubMed  Google Scholar 

  65. H. Agren, L. Wide, TRH tests with analyses of TSH, prolactin, and GH responses in subtypes of patients with major depressive disorders. Acta Psychiatr. Scand. 73, 549–558 (1986)

    CAS  PubMed  Google Scholar 

  66. L. Bartalena, G.F. Placidi, E. Martino, M. Falcone, L. Pellegrini, L. Dell’Osso, A. Pacchiarotti, A. Pinchera, Nocturnal serum thyrotropin (TSH) surge and the TSH response to TSH-releasing hormone: dissociated behavior in untreated depressives. J. Clin. Endocrinol. Metab. 71, 650–655 (1990)

    CAS  PubMed  Google Scholar 

  67. A.J. Rush, D.E. Giles, M.A. Schlesser, P.J. Orsulak, J.E. Weissenburger, C.L. Fulton, C.J. Fairchild, H.P. Roffwarg, Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression. Biol. Psychiatry 41, 915–928 (1997)

    CAS  PubMed  Google Scholar 

  68. E.A. Young, A. Korszun, The hypothalamic-pituitary-gonadal axis in mood disorders. Endocrinol. Metab. Clin. North Am. 31, 63–78 (2002)

    CAS  PubMed  Google Scholar 

  69. S.N. Seidman, S.P. Roose, The relationship between depression and erectile dysfunction. Curr. Psychiatry Rep. 2, 201–205 (2000)

    CAS  PubMed  Google Scholar 

  70. U. Schweiger, M. Deuschle, B. Weber, A. Körner, C.H. Lammers, J. Schmider, U. Gotthardt, I. Heuser, Testosterone, gonadotropin, and cortisol secretion in male patients with major depression. Psychosom. Med. 61, 292–296 (1999)

    CAS  PubMed  Google Scholar 

  71. A. Steiger, U. von Bardeleben, K. Wiedemann, F. Holsboer, Sleep EEG and nocturnal secretion of testosterone and cortisol in patients with major endogenous depression during acute phase and after remission. J. Psychiatr. Res. 25, 169–177 (1991)

    CAS  PubMed  Google Scholar 

  72. R.T. Rubin, R.E. Poland, I.M. Lesser, Neuroendocrine aspects of primary endogenous depression VIII. Pituitary-gonadal axis activity in male patients and matched control subjects. Psychoneuroendocrinology 14, 217–229 (1989)

    CAS  PubMed  Google Scholar 

  73. D.F. Swaab, A.M. Bao, P.J. Lucassen, The stress system in the human brain in depression and neurodegeneration. Ageing Res. Rev. 4, 141–194 (2005)

    CAS  PubMed  Google Scholar 

  74. F. Petraglia, S. Sutton, W. Vale, P. Plotsky, Corticotropin-releasing factor decreases plasma luteinizing hormone levels in female rats by inhibiting gonadotropin-releasing hormone release into hypophysial-portal circulation. Endocrinology 120, 1083–1088 (1987)

    CAS  PubMed  Google Scholar 

  75. E.L. Perez, J. Blouin, A. Blouin, The dexamethasone suppression test in bulimia: nonsuppression associated with depression and suboptimal weight. J. Clin. Psychiatry 49, 94–96 (1988)

    CAS  PubMed  Google Scholar 

  76. N. Piran, S. Kennedy, P.E. Garfinkel, M. Owens, Affective disturbance in eating disorders. J. Nerv. Ment. Dis. 173, 395–400 (1985)

    CAS  PubMed  Google Scholar 

  77. E.A. Lawson, D. Donoho, K.K. Miller, M. Misra, E. Meenaghan, J. Lydecker, T. Wexler, D.B. Herzog, A. Klibanski, Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa. J. Clin. Endocrinol. Metab. 94, 4710–4716 (2009)

    CAS  PubMed Central  PubMed  Google Scholar 

  78. K.R. Bruce, H. Steiger, M. Israël, P. Groleau, N.M. Ng Ying Kin, A.S. Ouellette, L. Sycz, G. Badawi, Cortisol responses on the dexamethasone suppression test among women with Bulimia-spectrum eating disorders: associations with clinical symptoms. Prog. Neuropsychopharmacol. Biol. Psychiatry 38, 241–246 (2012)

    CAS  PubMed  Google Scholar 

  79. R.G. Laessle, M. Fischer, M.M. Fichter, K.M. Pirke, J.C. Krieg, Cortisol levels and vigilance in eating disorder patients. Psychoneuroendocrinology 17, 475–484 (1992)

    CAS  PubMed  Google Scholar 

  80. C. Lauer, W. Schreiber, M. Berger, K.M. Pirke, F. Holsboer, J.C. Krieg, The effect of neuroendocrine secretion on brain morphology and EEG sleep in patients with eating disorders. Eur. Arch. Psychiatry Neurol. Sci. 238, 208–212 (1989)

    CAS  PubMed  Google Scholar 

  81. D.K. Katzman, E.K. Lambe, D.J. Mikulis, J.N. Ridgley, D.S. Goldbloom, R.B. Zipursky, Cerebral gray matter and white matter volume deficits in adolescent girls with anorexia nervosa. J. Pediatr. 129, 794–803 (1996)

    CAS  PubMed  Google Scholar 

  82. J. Castro-Fornieles, N. Bargalló, L. Lázaro, S. Andrés, C. Falcon, M.T. Plana, C. Junqué, A cross-sectional and follow-up voxel-based morphometric MRI study in adolescent anorexia nervosa. J. Psychiatr. Res. 43, 331–340 (2009)

    PubMed  Google Scholar 

  83. G.D. Giordano, P. Renzetti, R.C. Parodi, L. Foppiani, F. Zandrino, G. Giordano, F. Sardanelli, Volume measurement with magnetic resonance imaging of hippocampus-amygdala formation in patients with anorexia nervosa. J. Endocrinol. Invest. 24, 510–514 (2001)

    CAS  PubMed  Google Scholar 

  84. J.A. Seed, R.A. Dixon, S.E. McCluskey, A.H. Young, Basal activity of the hypothalamic-pituitary-adrenal axis and cognitive function in anorexia nervosa. Eur. Arch. Psychiatry Clin. Neurosci. 250, 11–15 (2000)

    CAS  PubMed  Google Scholar 

  85. J. Jolles, Neuropeptides and cognitive disorders. Prog. Brain Res. 65, 177–192 (1986)

    CAS  PubMed  Google Scholar 

  86. E.A. Lawson, A. Klibanski, Endocrine abnormalities in anorexia nervosa. Nat. Clin. Pract. Endocrinol. Metab. 4, 407–414 (2008)

    PubMed  Google Scholar 

  87. J.R. Newton, C.P. Freeman, W.J. Hannan, S. Cowen, Osteoporosis and normal weight bulimia nervosa–which patients are at risk? J. Psychosom. Res. 37, 239–247 (1993)

    CAS  PubMed  Google Scholar 

  88. S. Zipfel, M.J. Seibel, B. Löwe, P.J. Beumont, C. Kasperk, W. Herzog, Osteoporosis in eating disorders: a follow-up study of patients with anorexia and bulimia nervosa. J. Clin. Endocrinol. Metab. 86, 5227–5233 (2001)

    CAS  PubMed  Google Scholar 

  89. F. Jacoangeli, A. Zoli, A. Taranto, F. Staar Mezzasalma, C. Ficoneri, S. Pierangeli, G. Menzinger, M.R. Bollea, Osteoporosis and anorexia nervosa: relative role of endocrine alterations and malnutrition. Eat. Weight. Disord. 7, 190–195 (2002)

    CAS  PubMed  Google Scholar 

  90. B.M. Biller, V. Saxe, D.B. Herzog, D.I. Rosenthal, S. Holzman, A. Klibanski, Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. J. Clin. Endocrinol. Metab. 68, 548–554 (1989)

    CAS  PubMed  Google Scholar 

  91. K.A. Carmichael, D.H. Carmichael, Bone metabolism and osteopenia in eating disorders. Medicine (Baltimore) 74, 254–267 (1995)

    CAS  Google Scholar 

  92. M. Misra, R. Prabhakaran, K.K. Miller, M.A. Goldstein, D. Mickley, L. Clauss, P. Lockhart, J. Cord, D.B. Herzog, D.K. Katzman, A. Klibanski, Prognostic indicators of changes in bone density measures in adolescent girls with anorexia nervosa-II. J. Clin. Endocrinol. Metab. 93, 1292–1297 (2008)

    CAS  PubMed Central  PubMed  Google Scholar 

  93. S. Naessén, K. Carlström, R. Glant, H. Jacobsson, A.L. Hirschberg, Bone mineral density in bulimic women-influence of endocrine factors and previous anorexia. Eur. J. Endocrinol. 155, 245–251 (2006)

    PubMed  Google Scholar 

  94. ESHRE Capri Workshop Group, Nutrition and reproduction in women. Hum. Reprod. Update 12, 193–207 (2006)

    Google Scholar 

  95. U. Schweiger, K.M. Pirke, R.G. Laessle, M.M. Fichter, Gonadotropin secretion in bulimia nervosa. J. Clin. Endocrinol. Metab. 74, 1122–1127 (1992)

    CAS  PubMed  Google Scholar 

  96. M. Misra, K.K. Miller, J. Bjornson, A. Hackman, A. Aggarwal, J. Chung, M. Ott, D.B. Herzog, M.L. Johnson, A. Klibanski, Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J. Clin. Endocrinol. Metab. 88, 5615–5623 (2003)

    CAS  PubMed  Google Scholar 

  97. R.K. Støving, J.D. Veldhuis, A. Flyvbjerg, J. Vinten, J. Hangaard, O.G. Koldkjaer, J. Kristiansen, C. Hagen, Jointly amplified basal and pulsatile growth hormone (GH) secretion and increased process irregularity in women with anorexia nervosa: indirect evidence for disruption of feedback regulation within the GH-insulin-like growth factor I axis. J. Clin. Endocrinol. Metab. 84, 2056–2063 (1999)

    PubMed  Google Scholar 

  98. C. Bannai, N. Kuzuya, Y. Koide, T. Fujita, M. Itakura, K. Kawai, K. Yamashita, Assessment of the relationship between serum thyroid hormone levels and peripheral metabolism in patients with anorexia nervosa. Endocrinol. Jpn. 35, 455–462 (1988)

    CAS  PubMed  Google Scholar 

  99. H. Tamai, N. Kobayashi, S. Fukata, Y. Hirota, S. Matsubayashi, T. Nakagawa, M.C. Okimura, R.M. Walter Jr, L.F. Kumagai, Paradoxical responses of plasma cortisol, adrenocorticotropic hormone and growth hormone to thyrotropin-releasing hormone and luteinizing-hormone-releasing hormone in anorexia nervosa patients. Psychother. Psychosom. 46, 147–151 (1986)

    CAS  PubMed  Google Scholar 

  100. S. Grinspoon, L. Thomas, K. Miller, S. Pitts, D. Herzog, A. Klibanski, Changes in regional fat redistribution and the effects of estrogen during spontaneous weight gain in women with anorexia nervosa. Am. J. Clin. Nutr. 73, 865–869 (2001)

    CAS  PubMed  Google Scholar 

  101. L. Mayer, B.T. Walsh, R.N. Pierson Jr, S.B. Heymsfield, D. Gallagher, J. Wang, M.K. Parides, R.L. Leibel, M.P. Warren, E. Killory, D. Glasofer, Body fat redistribution after weight gain in women with anorexia nervosa. Am. J. Clin. Nutr. 81, 1286–1291 (2005)

    CAS  PubMed  Google Scholar 

  102. J. Balldin, U. Berggren, K. Bokström, G. Lindstedt, J. Sjöberg, C. Wendestam, Dexamethasone suppression test in alcohol withdrawal: relationship to depression and liver function. Drug Alcohol Depend. 30, 175–179 (1992)

    CAS  PubMed  Google Scholar 

  103. M.T. Abou-Saleh, J. Merry, A. Coppen, Dexamethasone suppression test in alcoholism. Acta Psychiatr. Scand. 69, 112–116 (1984)

    CAS  PubMed  Google Scholar 

  104. S.K. Majumdar, G.K. Shaw, P.K. Bridges, Relationship between plasma cortisol concentrations and depression in chronic alcoholic patients. Drug Alcohol Depend 14, 45–49 (1984)

    CAS  PubMed  Google Scholar 

  105. A. Heinz, H. Weingartner, D. George, D. Hommer, O.M. Wolkowitz, M. Linnoila, Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations. Psychiatry Res. 89, 97–106 (1999)

    CAS  PubMed  Google Scholar 

  106. N. Müller, M. Hoehe, H.E. Klein, G. Nieberle, H.P. Kapfhammer, F. May, O.A. Müller, M. Fichter, Endocrinological studies in alcoholics during withdrawal and after abstinence. Psychoneuroendocrinology 14, 113–123 (1989)

    PubMed  Google Scholar 

  107. M. Huntgeburth, H. Ten Freyhaus, S. Rosenkranz, Alcohol consumption and hypertension. Curr. Hypertens. Rep. 7, 180–185 (2005)

    CAS  PubMed  Google Scholar 

  108. J.F. Potter, L.T. Bannan, J.B. Saunders, M.C. Ingram, D.G. Beevers, Blood pressure and pressor mechanisms during alcohol withdrawal. J. Hypertens. Suppl. 1, 97–99 (1983)

    CAS  PubMed  Google Scholar 

  109. L.T. Bannan, J.F. Potter, D.G. Beevers, J.B. Saunders, J.R. Walters, M.C. Ingram, Effect of alcohol withdrawal on blood pressure, plasma renin activity, aldosterone, cortisol and dopamine beta-hydroxylase. Clin. Sci. (Lond) 66, 659–663 (1984)

    CAS  Google Scholar 

  110. D.B. Maurel, N. Boisseau, C.L. Benhamou, C. Jaffre, Alcohol and bone: review of dose effects and mechanisms. Osteoporos. Int. 23, 1–16 (2012)

    CAS  PubMed  Google Scholar 

  111. R.M. Couch, Dissociation of cortisol and adrenal androgen secretion in poorly controlled insulin-dependent diabetes mellitus. Acta Endocrinol. (Copenh.) 127, 115–117 (1992)

    CAS  Google Scholar 

  112. T.B. Kaye, R.A. Rubin, A.B. Goldfine, K. Rajamani, B.T. Kinsley, U.M. Vischer, D.C. Simonson, Effect of glycemic control on the overnight dexamethasone suppression test in patients with diabetes mellitus. J. Clin. Endocrinol. Metab. 74, 640–644 (1992)

    CAS  PubMed  Google Scholar 

  113. J.I. Hudson, M.S. Hudson, A.J. Rothschild, L. Vignati, A.F. Schatzberg, J.C. Melby, Abnormal results of dexamethasone suppression tests in nondepressed patients with diabetes mellitus. Arch. Gen. Psychiatry 41, 1086–1089 (1984)

    CAS  PubMed  Google Scholar 

  114. A.A. Mosbah, N.A. Abd-Ellatif, E.I. Sorour, Influence of serum cortisol levels on glycemic control in children with type 1 diabetes. J. Egypt Soc. Parasitol. 41, 777–784 (2011)

    PubMed  Google Scholar 

  115. G. Valsamakis, A. Anwar, J.W. Tomlinson, C.H. Shackleton, P.G. McTernan, R. Chetty, P.J. Wood, A.K. Banerjee, G. Holder, A.H. Barnett, P.M. Stewart, S. Kumar, 11beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 89, 4755–4761 (2004)

    CAS  PubMed  Google Scholar 

  116. S.B. Abraham, D. Rubino, N. Sinaii, S. Ramsey, L.K. Nieman, Cortisol, obesity and the metabolic syndrome: a cross-sectional study of obese subjects and review of the literature. Obesity 21, 105–117 (2013)

    Google Scholar 

  117. K.M. Oltmanns, B. Dodt, B. Schultes, H.H. Raspe, U. Schweiger, J. Born, H.L. Fehm, A. Peters, Cortisol correlates with metabolic disturbances in a population study of type 2 diabetic patients. Eur. J. Endocrinol. 154, 325–331 (2006)

    CAS  PubMed  Google Scholar 

  118. E. Rask, B.R. Walker, S. Söderberg, D.E. Livingstone, M. Eliasson, O. Johnson, R. Andrew, T. Olsson, Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity. J. Clin. Endocrinol. Metab. 87, 3330–3336 (2002)

    CAS  PubMed  Google Scholar 

  119. R.S. Lindsay, D.J. Wake, S. Nair, J. Bunt, D.E. Livingstone, P.A. Permana, P.A. Tataranni, B.R. Walker, Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. J. Clin. Endocrinol. Metab. 88, 2738–2744 (2003)

    CAS  PubMed  Google Scholar 

  120. L.L. Gathercole, P.M. Stewart, Targeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes. J. Steroid Biochem. Mol. Biol. 122, 21–27 (2010)

    CAS  PubMed  Google Scholar 

  121. R.C. Andrews, O. Rooyackers, B.R. Walker, Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes. J. Clin. Endocrinol. Metab. 88, 285–291 (2003)

    CAS  PubMed  Google Scholar 

  122. M. Hawkins, D. Hunter, P. Kishore, S. Schwartz, M. Hompesch, G. Hollis, R. Levy, B. Williams, R. Huber, INCB013739, a selective inhibitor of 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1), improves insulin sensitivity and lowers plasma cholesterol over 28 days in patients with type 2 diabetes mellitus. Diabetes 57(Suppl 1), A99–A100 (2008). (Abstract 1)

    Google Scholar 

  123. R.M. Reynolds, J. Labad, M.W. Strachan, A. Braun, F.G. Fowkes, A.J. Lee, B.M. Frier, J.R. Seckl, B.R. Walker, J.F. Price, Edinburgh Type 2 Diabetes Study (ET2DS) Investigators, Elevated fasting plasma cortisol is associated with ischemic heart disease and its risk factors in people with type 2 diabetes: the Edinburgh type 2 diabetes study. J. Clin. Endocrinol. Metab. 95, 1602–1608 (2010)

    CAS  PubMed Central  PubMed  Google Scholar 

  124. M. Peppa-Patrikiou, M. Scordili, A. Antoniou, M. Giannaki, M. Dracopoulou, C. Dacou-Voutetakis, Carotid atherosclerosis in adolescents and young adults with IDDM. Relation to urinary endothelin, albumin, free cortisol, and other factors. Diabetes Care 21, 1004–1007 (1998)

    CAS  PubMed  Google Scholar 

  125. C. Dacou-Voutetakis, M. Peppa-Patrikiou, M. Dracopoulou, Urinary free cortisol and its nyctohemeral variation in adolescents and young adults with IDDM: relation to endothelin 1 and indices of diabetic angiopathy. J. Pediatr. Endocrinol. Metab. 11, 437–445 (1998)

    CAS  PubMed  Google Scholar 

  126. I. Chiodini, G. Adda, A. Scillitani, F. Coletti, V. Morelli, S. Di Lembo, P. Epaminonda, B. Masserini, P. Beck-Peccoz, E. Orsi, B. Ambrosi, M. Arosio, Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications. Diabetes Care 30, 83–88 (2007)

    CAS  PubMed  Google Scholar 

  127. A.M. Stranahan, T.V. Arumugam, R.G. Cutler, K. Lee, J.M. Egan, M.P. Mattson, Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat. Neurosci. 11, 309–317 (2008)

    CAS  PubMed Central  PubMed  Google Scholar 

  128. H. Bruehl, O.T. Wolf, V. Sweat, A. Tirsi, S. Richardson, A. Convit, Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus. Brain Res. 1280, 186–194 (2009)

    CAS  PubMed Central  PubMed  Google Scholar 

  129. R.M. Reynolds, M.W. Strachan, J. Labad, A.J. Lee, B.M. Frier, F.G. Fowkes, R. Mitchell, J.R. Seckl, I.J. Deary, B.R. Walker, J.F. Price, Edinburgh Type 2 Diabetes Study Investigators, Morning cortisol levels and cognitive abilities in people with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetes Care 33, 714–720 (2010)

    CAS  PubMed Central  PubMed  Google Scholar 

  130. T.C. Sandeep, J.L. Yau, A.M. MacLullich, J. Noble, I.J. Deary, B.R. Walker, J.R. Seckl, 11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics. Proc. Natl. Acad. Sci. USA 101, 6734–6739 (2004)

    CAS  PubMed Central  PubMed  Google Scholar 

  131. M. Duong, J.I. Cohen, A. Convit, High cortisol levels are associated with low quality food choice in type 2 diabetes. Endocrine 41, 76–81 (2012)

    CAS  PubMed Central  PubMed  Google Scholar 

  132. M. Christ-Crain, B. Kola, F. Lolli, C. Fekete, D. Seboek, G. Wittmann, D. Feltrin, S.C. Igreja, S. Ajodha, J. Harvey-White, G. Kunos, B. Müller, F. Pralong, G. Aubert, G. Arnaldi, G. Giacchetti, M. Boscaro, A.B. Grossman, M. Korbonits, AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing’s syndrome. FASEB J. 22, 1672–1683 (2008)

    CAS  PubMed  Google Scholar 

  133. H. Djursing, H.C. Nyholm, C. Hagen, L. Carstensen, L.M. Pedersen, Clinical and hormonal characteristics in women with anovulation and insulin-treated diabetes mellitus. Am. J. Obstet. Gynecol. 143, 876–882 (1982)

    CAS  PubMed  Google Scholar 

  134. G. Reimondo, A. Pia, B. Allasino, F. Tassone, S. Bovio, G. Borretta, A. Angeli, M. Terzolo, Screening of Cushing’s syndrome in adult patients with newly diagnosed diabetes mellitus. Clin. Endocrinol. (Oxf) 67, 225–229 (2007)

    CAS  Google Scholar 

  135. B. Catargi, V. Rigalleau, A. Poussin, N. Ronci-Chaix, V. Bex, V. Vergnot, H. Gin, P. Roger, A. Tabarin, Occult Cushing’s syndrome in type-2 diabetes. J. Clin. Endocrinol. Metab. 88, 5808–5813 (2003)

    CAS  PubMed  Google Scholar 

  136. M. Terzolo, G. Reimondo, I. Chiodini, R. Castello, R. Giordano, E. Ciccarelli, P. Limone, C. Crivellaro, I. Martinelli, M. Montini, O. Disoteo, B. Ambrosi, R. Lanzi, M. Arosio, S. Senni, A. Balestrieri, E. Solaroli, B. Madeo, R. De Giovanni, F. Strollo, R. Battista, A. Scorsone, V.A. Giagulli, D. Collura, A. Scillitani, R. Cozzi, M. Faustini-Fustini, A. Pia, R. Rinaldi, B. Allasino, G. Peraga, F. Tassone, P. Garofalo, E. Papini, G. Borretta, Screening of Cushing’s syndrome in outpatients with type 2 diabetes: results of a prospective multicentric study in Italy. J. Clin. Endocrinol. Metab. 97, 3467–3475 (2012)

    CAS  PubMed  Google Scholar 

  137. I. Chiodini, M. Torlontano, A. Scillitani, M. Arosio, S. Bacci, S. Di Lembo, P. Epaminonda, G. Augello, R. Enrini, B. Ambrosi, G. Adda, V. Trischitta, Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case–control study in hospitalized patients. Eur. J. Endocrinol. 153, 837–844 (2005)

    CAS  PubMed  Google Scholar 

  138. R. Pasquali, S. Cantobelli, F. Casimirri, M. Capelli, L. Bortoluzzi, R. Flamia, A.M. Labate, L. Barbara, The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J. Clin. Endocrinol. Metab. 77, 341–346 (1993)

    CAS  PubMed  Google Scholar 

  139. R. Rosmond, M.F. Dallman, P. Björntorp, Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J. Clin. Endocrinol. Metab. 83, 1853–1859 (1998)

    CAS  PubMed  Google Scholar 

  140. E. Torrecilla, G. Fernández-Vázquez, D. Vicent, F. Sánchez-Franco, A. Barabash, L. Cabrerizo, A. Sánchez-Pernaute, A.J. Torres, M.A. Rubio, Liver upregulation of genes involved in cortisol production and action is associated with metabolic syndrome in morbidly obese patients. Obes. Surg. 22, 478–486 (2012)

    PubMed  Google Scholar 

  141. V. Vicennati, R. Pasquali, Abnormalities of the hypothalamic–pituitary–adrenal axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central and a peripheral alteration. J. Clin. Endocrinol. Metab. 85, 4093–4098 (2000)

    CAS  PubMed  Google Scholar 

  142. T. Reinehr, W. Andler, Cortisol and its relation to insulin resistance before and after weight loss in obese children. Horm. Res. 62, 107–112 (2004)

    CAS  PubMed  Google Scholar 

  143. D.J. Wake, E. Rask, D.E. Livingstone, S. Söderberg, T. Olsson, B.R. Walker, Local and systemic impact of transcriptional up-regulation of 11 beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity. J. Clin. Endocrinol. Metab. 88, 3983–3988 (2003)

    CAS  PubMed  Google Scholar 

  144. C. Wang, G. Jackson, T.H. Jones, A.M. Matsumoto, A. Nehra, M.A. Perelman, R.S. Swerdloff, A. Traish, M. Zitzmann, G. Cunningham, Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes. Diabetes Care 34, 1669–1675 (2011)

    CAS  PubMed Central  PubMed  Google Scholar 

  145. S. Wei, M.D. Schmidt, T. Dwyer, R.J. Norman, A.J. Venn, Obesity and menstrual irregularity: associations with SHBG, testosterone, and insulin. Obesity (Silver Spring). 17, 1070–1076 (2009)

    CAS  PubMed  Google Scholar 

  146. V. Vicennati, L. Ceroni, S. Genghini, L. Patton, U. Pagotto, R. Pasquali, Sex difference in the relationship between the hypothalamic–pituitary–adrenal axis and sex hormones in obesity. Obesity (Silver Spring). 14, 235–243 (2006)

    CAS  PubMed  Google Scholar 

  147. C.K. Buffington, J.R. Givens, A.E. Kitabchi, Enhanced adrenocortical activity as a contributing factor to diabetes in hyperandrogenic women. Metabolism 43, 584–590 (1994)

    CAS  PubMed  Google Scholar 

  148. T. Grimmichová, J. Vrbíková, P. Matucha, K. Vondra, P.P. Veldhuis, M.L. Johnson, Fasting insulin pulsatile secretion in lean women with polycystic ovary syndrome. Physiol. Res. 57(Suppl 1), 91–98 (2008)

    Google Scholar 

  149. M. Hollingdal, C.B. Juhl, R. Dall, J. Sturis, J.D. Veldhuis, O. Schmitz, N. Pørksen, Glucocorticoid induced insulin resistance impairs basal but not glucose entrained high-frequency insulin pulsatility in humans. Diabetologia 45, 49–55 (2002)

    CAS  PubMed  Google Scholar 

  150. M. Zarković, J. Cirić, Z. Penezić, B. Trbojević, M. Drezgić, Temporal coupling of luteinizing hormone and follicle stimulating hormone secretion in polycystic ovary syndrome. Gynecol. Endocrinol. 15, 381–388 (2001)

    PubMed  Google Scholar 

  151. R. Pascualy, Sleep apnea and type 2 diabetes. A vicious circle. Diabetes Self. Manag. 24, 29–30 (2007)

    PubMed  Google Scholar 

  152. G. Copinschi, Metabolic and endocrine effects of sleep deprivation. Essent. Psychopharmacol. 6, 341–347 (2005)

    PubMed  Google Scholar 

  153. J.C. Lam, C.S. Yan, A.Y. Lai, S. Tam, D.Y. Fong, B. Lam, M.S. Ip, Determinants of daytime blood pressure in relation to obstructive sleep apnea in men. Lung 187, 291–298 (2009)

    PubMed  Google Scholar 

  154. C. Parlapiano, M.C. Borgia, A. Minni, N. Alessandri, I. Basal, M. Saponara, Cortisol circadian rhythm and 24-hour Holter arterial pressure in OSAS patients. Endocr. Res. 31, 371–374 (2005)

    CAS  PubMed  Google Scholar 

  155. P.P. Roy-Byrne, T.W. Uhde, R.M. Post, W. Gallucci, G.P. Chrousos, P.W. Gold, The corticotropin-releasing hormone stimulation test in patients with panic disorder. Am. J. Psychiatry 143, 896–899 (1986)

    CAS  PubMed  Google Scholar 

  156. D.H. Avery, T.B. Osgood, D.M. Ishiki, L.G. Wilson, M. Kenny, D.L. Dunner, The DST in psychiatric outpatients with generalized anxiety disorder, panic disorder, or primary affective disorder. Am. J. Psychiatry 142, 844–848 (1985)

    CAS  PubMed  Google Scholar 

  157. R.G. Kathol, R. Anton, R. Noyes, T. Gehris, Direct comparison of urinary free cortisol excretion in patients with depression and panic disorder. Biol. Psychiatry 25, 873–878 (1989)

    CAS  PubMed  Google Scholar 

  158. R.G. Kathol, R. Noyes Jr, A.L. Lopez, J.H. Reich, Relationship of urinary free cortisol levels in patients with panic disorder to symptoms of depression and agoraphobia. Psychiatry Res. 24, 211–221 (1988)

    CAS  PubMed  Google Scholar 

  159. P. Westberg, K. Modigh, P. Lisjö, E. Eriksson, Higher postdexamethasone serum cortisol levels in agoraphobic than in nonagoraphobic panic disorder patients. Biol. Psychiatry 30, 247–256 (1991)

    CAS  PubMed  Google Scholar 

  160. B. Bandelow, D. Wedekind, V. Sandvoss, A. Broocks, G. Hajak, J. Pauls, H. Peter, E. Rüther, Diurnal variation of cortisol in panic disorder. Psychiatry Res. 95, 245–250 (2000)

    CAS  PubMed  Google Scholar 

  161. J.L. Abelson, G.C. Curtis, Hypothalamic–pituitary–adrenal axis activity in panic disorder. 24-hour secretion of corticotropin and cortisol. Arch. Gen. Psychiatry 53, 323–331 (1996)

    CAS  PubMed  Google Scholar 

  162. National Collaborating Centre for Mental Health (UK) Generalised Anxiety Disorder in Adults.: Management in Primary, Secondary and Community Care. pp 19. London: Royal College of Psychiatrists (2011)

  163. E.E. Schweizer, C.M. Swenson, A. Winokur, K. Rickels, G. Maislin, The dexamethasone suppression test in generalised anxiety disorder. Br. J. Psychiatry 149, 320–322 (1986)

    CAS  PubMed  Google Scholar 

  164. R.C. Mantella, M.A. Butters, J.A. Amico, S. Mazumdar, B.L. Rollman, A.E. Begley, C.F. Reynolds, E.J. Lenze, Salivary cortisol is associated with diagnosis and severity of late-life generalized anxiety disorder. Psychoneuroendocrinology 33, 773–781 (2008)

    CAS  PubMed Central  PubMed  Google Scholar 

  165. S.A. Vreeburg, F.G. Zitman, J. van Pelt, R.H. Derijk, J.C. Verhagen, R. van Dyck, W.J. Hoogendijk, J.H. Smit, B.W. Penninx, Salivary cortisol levels in persons with and without different anxiety disorders. Psychosom. Med. 72, 340–347 (2010)

    CAS  PubMed  Google Scholar 

  166. A. Pan, E.S. Schernhammer, Q. Sun, F.B. Hu, Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women. PLoS Med (2011). doi:10.1371/journal.pmed.1001141

    PubMed Central  PubMed  Google Scholar 

  167. L. Manenschijn, R.G. van Kruysbergen, F.H. de Jong, J.W. Koper, E.F. van Rossum, Shift work at young age is associated with elevated long-term cortisol levels and body mass index. J. Clin. Endocrinol. Metab. 96, 1862–1865 (2011)

    Google Scholar 

  168. H. Raff, H. Trivedi, Circadian rhythm of salivary cortisol, plasma cortisol, and plasma ACTH in end-stage renal disease. Endocr. Connect. 19, 23–31 (2012)

    Google Scholar 

  169. K. Carlström, A. Pousette, R. Stege, A. Lindholm, Serum hormone levels in men with end stage renal disease. Scand. J. Urol. Nephrol. 24, 75–78 (1990)

    PubMed  Google Scholar 

  170. F. Hammer, N.C. Edwards, B.A. Hughes, R.P. Steeds, C.J. Ferro, J.N. Townend, P.M. Stewart, The effect of spironolactone upon corticosteroid hormone metabolism in patients with early stage chronic kidney disease. Clin. Endocrinol. (Oxf) 73, 566–572 (2010)

    CAS  Google Scholar 

  171. M. Walser, S. Hill, Effect of ketoconazole plus low-dose prednisone on progression of chronic renal failure. Am. J. Kidney Dis. 29, 503–513 (1997)

    CAS  PubMed  Google Scholar 

  172. S.H. Shah, L.K. Newby, C-reactive protein: a novel marker of cardiovascular risk. Cardiol Rev. 11, 169–179 (2003)

    PubMed  Google Scholar 

  173. M.J. Sarnak, A.S. Levey, A.C. Schoolwerth, J. Coresh, B. Culleton, L.L. Hamm, P.A. McCullough, B.L. Kasiske, E. Kelepouris, M.J. Klag, P. Parfrey, M. Pfeffer, L. Raij, D.J. Spinosa, P.W. Wilson, American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention: kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Hypertension 42, 1050–1065 (2003)

    CAS  PubMed  Google Scholar 

  174. B.J. Carroll, A. Iranmanesh, D.M. Keenan, F. Cassidy, W.H. Wilson, J.D. Veldhuis, Pathophysiology of hypercortisolism in depression: pituitary and adrenal responses to low glucocorticoid feedback. Acta Psychiatr. Scand. 125, 478–491 (2012)

    CAS  PubMed Central  PubMed  Google Scholar 

  175. J. Licinio, M.L. Wong, P.W. Gold, The hypothalamic–pituitary–adrenal axis in anorexia nervosa. Psychiatry Res. 62, 75–83 (1996)

    CAS  PubMed  Google Scholar 

  176. G.S. Birketvedt, E. Drivenes, I. Agledahl, J. Sundsfjord, R. Olstad, J.R. Florholmen, Bulimia nervosa: a primary defect in the hypothalamic–pituitary–adrenal axis? Appetite 46, 164–167 (2006)

    CAS  PubMed  Google Scholar 

  177. T.P. Beresford, D.B. Arciniegas, J. Alfers, L. Clapp, B. Martin, H.F. Beresford, Y. Du, D. Liu, D. Shen, C. Davatzikos, M.L. Laudenslager, Hypercortisolism in alcohol dependence and its relation to hippocampal volume loss. J. Stud. Alcohol 67, 861–867 (2006)

    PubMed  Google Scholar 

  178. A. Smals, P. Kloppenborg, Alcohol-induced pseudo-Cushings syndrome. Lancet 1, 1369 (1977)

    CAS  PubMed  Google Scholar 

  179. R.H. Stimson, R. Andrew, N.C. McAvoy, D. Tripathi, P.C. Hayes, B.R. Walker, Increased whole-body and sustained liver cortisol regeneration by 11 beta-hydroxysteroid dehydrogenase type 1 in obese men with type 2 diabetes provides a target for enzyme inhibition. Diabetes 60, 720–725 (2011)

    CAS  PubMed Central  PubMed  Google Scholar 

  180. R. Pasquali, V. Vicennati, Activity of the hypothalamic-pituitary-adrenal axis in different obesity phenotypes. Int. J. Obes. Relat. Metab. Disord. 24(Suppl 2), 47–49 (2000)

    Google Scholar 

  181. R. Pasquali, V. Vicennati, A. Gambineri, Adrenal and gonadal function in obesity. J. Endocrinol. Invest. 25, 893–898 (2002)

    CAS  PubMed  Google Scholar 

  182. B.R. Walker, R. Andrew, Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease. Ann. N. Y. Acad. Sci. 1083, 165–184 (2006)

    CAS  PubMed  Google Scholar 

  183. R. Desbriere, V. Vuaroqueaux, V. Achard, S. Boullu-Ciocca, M. Labuhn, A. Dutour, M. Grino, 11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients. Obesity (Silver Spring) 14, 794–798 (2006)

    CAS  Google Scholar 

  184. T. Tsilchorozidou, J.W. Honour, G.S. Conway, Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5 alpha-reduction but not the elevated adrenal steroid production rates. J. Clin. Endocrinol. Metab. 88, 5907–5913 (2003)

    CAS  PubMed  Google Scholar 

  185. F. Roelfsema, P. Kok, A.M. Pereira, H. Pijl, Cortisol production rate is similarly elevated in obese women with or without the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 95, 3318–3324 (2010)

    CAS  PubMed  Google Scholar 

  186. A. Gambineri, G. Forlani, A. Munarini, F. Tomassoni, G.E. Cognigni, W. Ciampaglia, U. Pagotto, B.R. Walker, R. Pasquali, Increased clearance of cortisol by 5 beta-reductase in a subgroup of women with adrenal hyperandrogenism in polycystic ovary syndrome. J. Endocrinol. Invest. 32, 210–218 (2009)

    CAS  PubMed  Google Scholar 

  187. L.M. Tomfohr, K.M. Edwards, J.E. Dimsdale, Is obstructive sleep apnea associated with cortisol levels? A systematic review of the research evidence. Sleep Med. Rev. 16, 243–249 (2012)

    PubMed Central  PubMed  Google Scholar 

  188. T.M. Buckley, A.F. Schatzberg, On the interactions of the hypothalamic–pituitary–adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J. Clin. Endocrinol. Metab. 90, 3106–3114 (2005)

    CAS  PubMed  Google Scholar 

  189. M. Clodi, M. Riedl, S. Schmaldienst, A. Vychytil, H. Kotzmann, A. Kaider, C. Bieglmayer, G. Mayer, W. Waldhäusl, A. Luger, Adrenal function in patients with chronic renal failure. Am. J. Kidney Dis. 32, 52–55 (1998)

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This article did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector

Conflict of interest

The authors declare they have no conflict of interest.

Author information

Authors and Affiliations

  1. Division of Endocrinology, Department of Clinical and Molecular Sciences, Umberto I Hospital, Polytechnic University of Marche, Ancona, Italy

    Giacomo Tirabassi, Marco Boscaro & Giorgio Arnaldi

Authors
  1. Giacomo Tirabassi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marco Boscaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giorgio Arnaldi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giorgio Arnaldi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tirabassi, G., Boscaro, M. & Arnaldi, G. Harmful effects of functional hypercortisolism: a working hypothesis. Endocrine 46, 370–386 (2014). https://doi.org/10.1007/s12020-013-0112-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-013-0112-y

Keywords

Search

Navigation